Tropic Biosciences Competitors and Similar CompaniesClear all
Tropic Biosciences's competitors and similar companies include Novavax, Phasefocus and SEPPURE.
 Tropic Biosciences Tropic Biosciences is a biotechnology company that uses advanced plant breeding and gene editing technologies to develop commercial tropical crops such as coffee, rice, and bananas. |  Novavax Novavax is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. |  Phasefocus Phasefocus is a company offering lensless microscopy technology for radar, ultra-violet and infra-red imaging, and terahertz imaging applications. |  SEPPURE SEPPURE develops sustainable nano-filtration solutions intended to separate chemical mixtures at a molecular level with minimal energy use. | |
Founding Date | Founding Date 2016 | Founding Date 1987 | Founding Date 2006 | Founding Date 2018 |
Type | Type Private | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations Norfolk, GB HQ | Locations Gaithersburg, US HQ Jevany, CZ Uppsala, SE Rockville, US | Locations Sheffield, GB HQ London, GB | Locations Singapore, SG HQ Calgary, CA Singapore, SG |
Employees | Employees 164 | Employees 16845% decrease | Employees 9 | Employees 38 |
Financial | ||||
Revenue (est.) | Revenue (est.) £730.1k (FY, 2023) | Revenue (est.) $1.1b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods £424.5k (FY, 2023) | Cost of goods $73m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit £305.6k (FY, 2023) | Gross profit $1.1b (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income (£14.8m) (FY, 2023) | Net income $440.3m (FY, 2025) | Net income N/A | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round $ 28.5m (about 6 years ago) | Latest funding round N/A | Latest funding round $ 5m (about 14 years ago) | Latest funding round $ 2.6m (almost 7 years ago) |
Total funding raised | Total funding raised $ 38.5m | Total funding raised N/A | Total funding raised $ 6.8m | Total funding raised $ 2.8m |
For sources of this data, please see the company profile
View Company Profiles
Novavax
HQ
Gaithersburg, US
Employees
168↓ 45% decrease
Novavax is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases.
View companyPhasefocus
HQ
Sheffield, GB
Employees
9
Phasefocus is a company offering lensless microscopy technology for radar, ultra-violet and infra-red imaging, and terahertz imaging applications.
View companySEPPURE
HQ
Singapore, SG
Employees
38
SEPPURE develops sustainable nano-filtration solutions intended to separate chemical mixtures at a molecular level with minimal energy use.
View company